Pharyngeal muscle weakness and dysphagia is common in individuals post-stroke or with Parkinson’s disease and in individuals with head/neck cancer who have undergone surgery and/or radiation therapy. Therapeutic options for these patients are limited. In collaboration with our Speech Pathology colleagues, this pilot study is intended to assess the feasibility, safety, and efficacy of the External Pharyngeal Exerciser (EPE) on patients with pharyngeal dysphagia receiving swallow therapy. Studies are underway: ClinicalTrials.gov NCT05267314